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Volume 58, Number 5 Abstracts 1431GA group vs 73% in the CBA group (P ¼ .0085). Thirty percent of all
patients required both vasopressors and antihypertensives during surgery;
23% (CBA) vs 34% (GA; P ¼ .0457). There were no postoperative compli-
cations or mortality in the CBA cohort. The GA cohort developed postop-
erative complications (myocardial infarctions, 4; stroke, 6; hematoma, 9);
however, these complications were not statistically signiﬁcant compared
with the CBA group.
Conclusions: For patients undergoing CEA, CBA resulted in less
hemodynamic ﬂuctuations and fewer vasvasoactive medication requirements
as compared with GA.Table. Outcomes for 31 cardiac support device (CSD) recipients who
experienced extremity vascular complications (EVC)
Permanent
VAD
Temporary
VAD ECMO
CSD recipients experi-
encing EVC
13 10 8
Outcomes
Any vascular procedure,
n (%)
7 (53.9%) 9 (90.0%) 6 (75.0%)
Revascularization, n (%) 5 (38.5%) 4 (40.0%) 2 (25.0%)
Amputation, n (%) 0 (0.0%) 1 (10.0%) 1 (12.5%)
Withdrawal of care, n (%) 3 (23.1%) 8 (80.0%) 4 (50.0%)
Time to death after
EVC, days (6 SEM)
60.14 6 21.48 15.38 6 2.34 15.20 6 7.21
30-day mortality after
EVC, n (%)
2 (15.4%) 8 (80.0%) 4 (50.0%)
ECMO, Extracorporeal membrane oxygenation; SEM, standard error of the
mean; VAD, ventricular assist device.
Fig. BP, Blood pressureEndovascular Repair of Popliteal Artery Aneurysm: A Comparison of
Outcomes with Contemporary Open Surgical Repair
Ying Huang, Peter Gloviczki, Gustavo S. Oderich, Audra A. Duncan,
Manju Kalra, Mark D. Fleming, Thomas C. Bower. Mayo Clinic,
Rochester, Minn
Objectives: To compare outcomes after endovascular repair (ER) and
open surgical repair (OR) of popliteal artery aneurysms (PAAs).
Methods: Clinical data of PAA patients treated between 2005 and
2012 were reviewed. Primary endpoints were major adverse events
(MAE) including mortality, thrombosis, amputation, complications, and
reinterventions.
Results: A total of 46 limbs of 38 patients (37 males; mean age, 81
6 6.4 years) were treated with ER, electively (n ¼ 34) or emergently (n ¼
12). A mean of 2.0 Viabahn stent grafts were used. Thirty-day mortality
and amputation was 0 after elective ER and 17% (2/12) after emergencies.
Thirty-day patency was 100% after elective ER and 75% (3/12) after emer-
gencies. MAE was 8.8% after elective and 58% after emergency ER (P ¼
.0007). Mean follow-up was 2.3 years (range, 1 month to 6.0 years).
Three-year primary and secondary patencies were 72% and 82% for elec-
tives and 60% and 83% for emergencies (P > .05), freedoms from reinter-
vention were equivalent (69% vs 55%), and limb salvage and freedom from
MAE rates were higher for electives than for emergencies (100% vs 83%
and 63% vs 30%; P < .05). One hundred ten limbs of 91 patients (90
males; mean age, 71 6 9.8 years) were treated with OR, electively (n ¼
98) or emergently (n ¼ 12). Autogenous veins (n ¼ 89) or PTFE (n ¼
21) were used as bypass grafts. Thirty-day amputation rate was 0, one
patient died (1%), and one graft (1%) thrombosed after elective OR.
Thirty-day MAE was 7.1% after elective and 33% after emergency OR (P
¼ .02). Mean follow-up was 3.4 years (range, 1 month to 8.0 years).
Three-year primary and secondary patencies were 82% and 90% for elec-
tives, 83% and 92% for emergencies (P > .05), limb salvage rates were
similar (99% vs 100%), and freedoms from reintervention and freedom
from MAE rates were higher for electives than for emergencies (85% vs
67% and 77% vs 58%; P < .05). ER and OR in elective interventions
had similar patencies and MAE; hospitalization was longer after OR.
Emergency repair prolonged intensive care unit stay after ER but hospital
days, patencies, and MAE were similar. Factors affecting MAE included
ER and emergency repair.
Conclusions: PAAs with ER and emergency repair continue to have
elevated MAEs. Both elective ER and OR have excellent early results and
similar late outcome. Selective use of ER in patients who need emergency
repair is clearly warranted.The Effect of Extremity Vascular Complications on the Outcomes of
Cardiac Support Device Recipients
J. Westley Ohman, Chandu Vemuri, Sunil Prasad, Scott Silvestry, Jeffrey
Jim, Patrick Geraghty. Washington University St. Louis, St. Louis, Mo
Objectives: To assess the effect of extremity vascular complica-
tions (EVC; including ischemia and vessel trauma) on the outcomes
of patients receiving cardiac support devices (CSD; including ventric-
ular assist device [VAD] and extracorporeal membrane oxygenation
[ECMO]).
Methods: Institutional review board-approved, retrospective review
of a prospectively maintained database of all temporary and permanent
CSD recipients from 7/1/10 to 6/30/12. Patient demographics, proce-
dural data, and outcomes were analyzed. The primary endpoint was all-
cause mortality at 30 days post-CSD initiation.
Results: Of 208 patients who received CSDs, 31 (14.9%) experienced
EVC: 13 (8.9%) of the 146 permanent VADs, 10 (26.3%) of the 38 tempo-
rary VADs, and eight (33.3%) of the 24 ECMO patients. The 30-day
mortality was signiﬁcantly higher for temporary VAD patients who experi-
enced EVC versus those that did not (80.0% vs 35.7%; P ¼ .03). However,
30-day mortality was not signiﬁcantly impacted by EVC in the permanent
VAD (15.4% EVC vs 4.5% without EVC; P ¼ .15) and ECMO patients
(50.0% vs 68.75%; P ¼ 1.00). Preinitiation peripheral arterial disease and
cardiogenic shock did not signiﬁcantly differ between the CSD groups.
Outcomes for CSD subgroups following the occurrence of EVC are shown
in Table.Conclusions: In temporary VAD recipients, the development of
extremity vascular complications results in higher 30-day mortality and
more frequent withdrawal of care. In contrast, extremity vascular complica-
tions in the permanent VAD and ECMO groups did not signiﬁcantly impact
mortality or withdrawal of care. This prognostic data may be useful in the
management of these challenging patients.
Altered Sca-1+ Progenitor Cell Populations in Diabetic Mice Are
Associated with Increased Neointimal Hyperplasia After Vascular
Injury
Jill R. Streams, Janet Martinez, Megan Flynn, Melina R. Kibbe. Department
of Vascular Surgery, Northwestern University, Chicago, Ill
Objectives: Diabetic patients exhibit poor outcomes after vascular
interventions, predominantly due to development of neointimal hyperplasia.
While diabetic mice have been shown to have diminished Sca-1+ stem cells
in their bone marrow, the role of Sca-1+ cells in the vasculature is unknown.
We hypothesize that diabetic mice have diminished Sca-1+ stem cell popu-
lations in the arterial wall compared with wild type (WT) mice. We also
hypothesize that vascular injury will alter the presence and distribution of
Sca-1+ cells in the arterial wall.
Methods: The femoral artery wire injury model was performed in 8-
to 12-week-old male Lepr db/db diabetic and C57BL/6 WT mice. Treat-
ment groups included control and injury. Femoral arteries were harvested
at 24 hours and 3 days and assessed for Sca-1+ cells with immunoﬂuores-
cence (n ¼ 5). Sca-1+ staining was graded on a scale of 0 to 4 in four
